Aby wyświetlić tę treść, wymagana jest subskrypcja JoVE. Zaloguj się lub rozpocznij bezpłatny okres próbny.
Method Article
We present the techniques required to isolate the stromal vascular fraction (SVF) from mouse inguinal (subcutaneous) and perigonadal (visceral) adipose tissue depots to assess their gene expression and collagenolytic activity. This method includes the enrichment of Sca1high adipose-derived stem cells (ASCs) using immunomagnetic cell separation.
The isolation of adipose-derived stem cells (ASCs) is an important method in the field of adipose tissue biology, adipogenesis, and extracellular matrix (ECM) remodeling. In vivo, ECM-rich environment consisting of fibrillar collagens provides a structural support to adipose tissues during the progression and regression of obesity. Physiological ECM remodeling mediated by matrix metalloproteinases (MMPs) plays a major role in regulating adipose tissue size and function1,2. The loss of physiological collagenolytic ECM remodeling may lead to excessive collagen accumulation (tissue fibrosis), macrophage infiltration, and ultimately, a loss of metabolic homeostasis including insulin resistance3,4. When a phenotypic change of the adipose tissue is observed in gene-targeted mouse models, isolating primary ASCs from fat depots for in vitro studies is an effective approach to define the role of the specific gene in regulating the function of ASCs. In the following, we define an immunomagnetic separation of Sca1high ASCs.
Stem cell antigen 1 (Sca1, or Ly6A/E) was first identified as a cell surface marker expressed by hematopoietic and mesenchymal stem cells5,6. The stromal vascular fraction (SVF) of adipose tissue obtained from mouse fat depots is a heterogeneous population of cells comprising of fibroblasts, macrophages, vascular endothelial cells, neuronal cells, and adipocyte progenitor cells7. Adipocyte progenitor cells, or adipose-derived stem cells (ASCs) are non-lipid-laden cells that reside in the collagen-rich perivascular extracellular matrix (ECM)8. Approximately 50% of the SVF consist of ASCs, which are characterized as lineage-negative (Lin....
Access restricted. Please log in or start a trial to view this content.
Ethics Statement: The University of Michigan Committee on Use and Care of Animals (UCUCA) has approved all methods and protocols in accordance with the Guide for the Care and Use of Laboratory Animals (Institute for Laboratory Animal Research, National Research Council). Mice are maintained in a University of Michigan vivarium and are given free access to food and water and kept on a 12 hr dark/light cycle.
1. Preparations
Access restricted. Please log in or start a trial to view this content.
Enrichment of Sca1high ASCs from Different Fat Pads.
The vascular stromal cells isolated from SQ fat display fibroblast-like, stretched cell shape regardless of Sca1 expression level (Figure 1A). On the other hand, VIS (eWAT-derived) Sca1high and Sca1low cells demonstrate distinct difference in their cell shape. Like SQ (iWAT-derived) Sca1high cells, VIS (eWAT-derived).......
Access restricted. Please log in or start a trial to view this content.
Herein we demonstrate the isolation and immunomagnetic cell separation of murine ASCs from different fat pads and their use for in vitro experiments. The presented method is effective for the quick isolation of large number of Sca1-positive ASCs, which is advantageous over the technically complex and expensive FACS-mediated isolation of ASCs9,14. Unlike FACS, immunomagnetic cell separation does not allow the use of multiple antigen for the identification of a target cell population. Nonetheless, if th.......
Access restricted. Please log in or start a trial to view this content.
The authors have nothing to disclose.
This work is supported by NIH DK095137 (to THC). We thank the current and former lab members who contributed to the development and sophistication of the described methods.
....Access restricted. Please log in or start a trial to view this content.
Name | Company | Catalog Number | Comments |
Type 3 Collagenase | Worthington Biochemical | LS004182 | Tissue digestion |
DMEM | Gibco | 11965-092 | High-glucose culture medium |
Pen/Strep/Glutamine (100x) | Gibco | 10378-016 | Media antibiotic |
Anti-anti (100x) | Gibco | 15240-062 | Media antifungal |
FBS | Gibco | 16000-044 | |
PBS (1x, pH 7.4) | Gibco | 10010-023 | |
Trypsin (0.05%) | Gibco | 25300-054 | |
Cell strainer | BD Bioscience | 352360 | 100-μm cell strainer |
60 mm plates | BD Falcon | 353004 | |
Scissors | FST | 14001-12 | Large |
Scissors | FST | 14091-11 | Fine, curved tip |
Large Forceps | FST | 11000-12 | |
Fine Forceps | Any vendor | ||
25G 5/8” needles | BD | 305122 | |
22G 1.5” needles | BD | 305159 | |
15 ml conical tubes | BD Falcon | 352097 | |
50 ml conical tubes | BD Falcon | 352098 | |
MACS separation columns | Miltenyi Biotec | 130-042-201 | |
Anti-Sca1 microbead kit (FITC) | Miltenyi Biotec | 130-092-529 | FITC-anti-Sca1 1ºAb and anti-FITC microbeads 2ºAb |
AutoMACS running buffer | Miltenyi Biotec | 130-091-221 | |
MiniMACS separator | Miltenyi Biotec | 130-042-102 | |
MACS MultiStand | Miltenyi Biotec | 130-042-303 | |
Blue chux pads | Fisher | 276-12424 | |
Absorbent pads | Fisher | 19-165-621 | |
Styrofoam board | Use from 50 ml tubes | ||
70% ethanol | |||
Isoflurane | Any vendor | ||
Rat IgG2a Alexa Fluor 647 | Invitrogen | R2a21 | |
Rat IgG2a anti-mouse Sca1 Alexa Fluor 647 | Invitrogen | MSCA21 | |
Rat IgG2a R-PE | Invitrogen | R2a04 | |
Rat IgG2a anti-mouse F4/80 R-PE | Invitrogen | MF48004 | |
Round-bottom tube | BD Falcon | 352058 | |
HBSS (–Ca, –Mg) | Gibco | 14175-095 | |
HBSS (+Ca, +Mg) | Gibco | 14025-092 | For collagenase solution |
Type I collagen (2.7 mg/ml in 37mm acetic acid | Prepare in house12 | ||
10x MEM | Gibco | 11430-030 | |
1 M HEPES | Gibco | 15630-080 | |
0.34 N NaOH | Prepare in house | ||
Cover slips | Corning | 2870-22 | |
Alexa Fluor 594 carboxylic acid, succinimidyl ester, mixed isomers | Invitrogen | A-20004 | |
0.89 M NaHCO3 | Gibco | 25080-094 |
Access restricted. Please log in or start a trial to view this content.
Zapytaj o uprawnienia na użycie tekstu lub obrazów z tego artykułu JoVE
Zapytaj o uprawnieniaThis article has been published
Video Coming Soon
Copyright © 2025 MyJoVE Corporation. Wszelkie prawa zastrzeżone